期刊文献+

蜕皮甾酮对胰岛素抵抗细胞模型胰岛素敏感性和糖代谢的影响 被引量:41

Effects of ecdysterone on insulin sensitivity and glucose metabolism in insulin-resistant cell model
下载PDF
导出
摘要 目的应用高胰岛素体外诱导培养建立的胰岛素抵抗HepG2细胞模型探讨蜕皮甾酮对其胰岛素敏感性和糖代谢的影响。方法采用^3H-D-葡萄糖的参人试验评价细胞的胰岛素敏感性,在诱导胰岛素抵抗HepG2细胞模型的过程中或模型建立后,培养液中加入蜕皮甾酮及吡格列酮共同孵育,观察蜕皮甾酮及吡格列酮对HepG2细胞葡萄糖参人率,同时观察蜕皮甾酮对胰岛素抵抗细胞模型葡萄糖消耗量的影响。结果含有蜕皮甾酮(浓度为1×10^-6~10^-4mol·L^-1)的胰岛素抵抗HepG2细胞的葡萄糖参入率与葡萄糖消耗量明显高于不含蜕皮甾酮的胰岛素抵抗HepG2细胞(对照细胞,P〈0.01)。蜕皮甾酮与吡格列酮对胰岛素抵抗模型细胞的葡萄糖参人率与葡萄糖消耗量差异无显著性(P〉0.05)。结论蜕皮甾酮在胰岛素抵抗细胞模型中能提高胰岛素介导的葡萄糖摄取和利用能力,即增加胰岛素的敏感性;并能明显改善糖代谢。 Aim To investigate the effects of ecdysterone on insulin sensitivity and glucose metabolism in the insulin resistant HepG2 cell model induced by high concentration of insulin. Methods The insulin-stimulated glucose incorporation rate was determined with 3H-D-glucose uptake test which was used to estimate insulin sensitivity of HepG2 cell, and glucose consumption, the amounts of glucose disappeared from the culture medium of HepG2 cells within 24 h were determined. Results The incubation of insulin resistance cells with ecdysterone 1×10^-6 - 10^-4 mol · L^-1 could significantly increase the glucose uptake and glucose consumption of the cells compared with that of control cells(P 〈0. 01 ). The glucose uptake and glucose consumption of insulin resistance ceils were not of the difference in the insulin resistance ceils with ecdysterone and pioglitazone ( P 〉 0. 05 ). Conclusion Ecdysterone could improve the insulin sensitivity in the cell model and can attenuate the aggression of insulin resistance. The effect to improve the insulin sensitivity with ecdysterone is similar to that with pioglitazone.
出处 《中国药理学通报》 CAS CSCD 北大核心 2006年第4期460-464,共5页 Chinese Pharmacological Bulletin
基金 重庆市自然科学基金资助课题(No20038012)
关键词 蜕皮甾酮 胰岛素抵抗 细胞模型 胰岛素敏感性 ecdysterone insulin resistance cell model insulin sensitivity
  • 相关文献

参考文献10

  • 1Lebovitz H E.The relationship of obesity to the metabolic syndrome[J].Int J Clin Pract (Suppl),2003,134:18-27.
  • 2Shobokshi A,Shaarawy M.Correction of insulin resistance and hyperandrogenism in polycystic ovary syndrome by combined rosiglitazone and clomiphene citrate therapy[J].J Soc Gynecol Investig,2003,10(2):99-104.
  • 3陈秋,夏永鹏,邱宗荫.蜕皮甾酮对HepG2细胞葡萄糖消耗的影响[J].中国药理学通报,2005,21(11):1358-1362. 被引量:16
  • 4陈秋,夏永鹏,邱宗荫.吡格列酮对胰岛素抵抗HepG2细胞模型的药理学评价[J].中国药理学通报,2006,22(2):248-251. 被引量:33
  • 5Shibasaki M,Takahashi K,Itou T,et al.A PPAR agonist improves TNF-alpha-induced insulin resistance of adipose tissue in mice[J].Biochem Biophys Res Commun,2003,309(2):419-24.
  • 6Doggrell S.Do peroxisome proliferation receptor-gamma antagonists have clinical potential as combined antiobesity and antidiabetic drugs?[J].Expert Opin Investig Drugs,2003,12(4):713-6.
  • 7Santure M,Pitre M,Nadeau A,et al.Effect of troglitazone on vascular and glucose metabolic actions of insulin in high-sucrose-fed rats[J].Metabolism,2003,52(8):978-86.
  • 8Chen Y N,Chen S Y,Zeng L J,et al.Secondary sulphonylurea failure:What pathogenesis is responsible?[J].Br J Biomed Sci,2003,60(1):9-13.
  • 9Muurling M,Mensink R P,Pijl H,et al.Rosiglitazone improves muscle insulin sensitivity,irrespective of increased triglyceride content,in ob/ob mice[J].Metabolism,2003,52(8):1078-83.
  • 10Lenhard J M,Kliewer S A,Paulik M A,et al.Effects of troglitazone and metformin on glucose and lipid metabolism[J].Biochem Pharmacy,1997,54:801-8.

二级参考文献14

  • 1Gurnell M,Savage DB,Chatterjee VK et al.The metabolic syndrome:Peroxisome proliferator-activated receptor gamma and its therapeutic modulation[J].J Clin Endocrinol Metab,2003,88(6):2412-21.
  • 2Tadayyon M,Smith SA.Insulin sensitisation in the treatment of Type diabetes[J].Expert Opin Investig Drugs,2003,12(3):307-24.
  • 3Melin B,Cherqui G,Blivet MJ et al.Dual effect of metformin in cultured rat hepatocytes:potentiation of insulin action and prevention of insulin-induced insulin resistance[J].Metabolism,1990,39:1089.
  • 4Arakawa K,Ishihara T,Auto M et al.Action of novel antidiabetic thiazolidinedione,T-174,in animals of non-insulin-dependent diabetes mellitus(NIDDM) and in cultured muscle cells[J].Br J Pharmacol,1998,125:429-36.
  • 5Senn JJ,Klover PJ,Nowak IA et al.Interleukin-6 induces cellular insulin resistance in hepatocytes[J].Diabetes,2002,51(12):3391-9
  • 6Bernal MC,Weng S,Finck BN et al.Dexamethasone induction of hypertension and diabetes is PPAR-alpha dependent in LDL receptor-null mice[J].Nat Med,2003,9(8):1069-75.
  • 7Camp HS.Thiazolidinediones in diabetes:Current status and future outlook[J].Curr Opin Investig Drugs,2003,4(4):406-11.
  • 8Santure M,Pitre M,Nadeau A et al.Effect of troglitazone on vascular and glucose metabolic actions of insulin in high-sucrose-fed rats[J].Metabolism,2003,52(8):978-86.
  • 9Julia A,Barman B,Greg L.Rosiglitazone[J].Drugs,1999,57:921-7.
  • 10徐楠杰,郭月英,李铣.蜕皮甾酮的药理作用研究进展[J].沈阳药科大学学报,1997,14(4):300-302. 被引量:37

共引文献46

同被引文献572

引证文献41

二级引证文献444

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部